This company listing is no longer active
B7Y Stock Overview
Develops and commercialize antimicrobial technologies and products in the United Kingdom, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Byotrol plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.0005 |
| 52 Week High | €0.018 |
| 52 Week Low | €0.0005 |
| Beta | 1.35 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -96.00% |
| 3 Year Change | -99.28% |
| 5 Year Change | -96.77% |
| Change since IPO | -98.39% |
Recent News & Updates
Recent updates
Shareholder Returns
| B7Y | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.9% | -1.6% |
| 1Y | -96.0% | -8.8% | 6.8% |
Return vs Industry: B7Y underperformed the German Chemicals industry which returned 3.7% over the past year.
Return vs Market: B7Y underperformed the German Market which returned 3.9% over the past year.
Price Volatility
| B7Y volatility | |
|---|---|
| B7Y Average Weekly Movement | 0% |
| Chemicals Industry Average Movement | 3.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.6% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: B7Y's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine B7Y's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 36 | David Traynor | byotrolplc.com |
Byotrol plc develops and commercialize antimicrobial technologies and products in the United Kingdom, North America, and internationally. The company operates through Professional and Consumer segments. Its product portfolio includes Actizone, a antimicrobial technology which improves cleaning performance and long-lasting protection against bacteria; and Byotrol, a long-lasting antimicrobial protection for various applications including bathroom cleaners to multi-surface wipes.
Byotrol plc Fundamentals Summary
| B7Y fundamental statistics | |
|---|---|
| Market cap | €226.95k |
| Earnings (TTM) | -€2.18m |
| Revenue (TTM) | €5.14m |
0.0x
P/S Ratio-0.1x
P/E RatioIs B7Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| B7Y income statement (TTM) | |
|---|---|
| Revenue | UK£4.38m |
| Cost of Revenue | UK£2.52m |
| Gross Profit | UK£1.86m |
| Other Expenses | UK£3.72m |
| Earnings | -UK£1.85m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0041 |
| Gross Margin | 42.51% |
| Net Profit Margin | -42.33% |
| Debt/Equity Ratio | 19.7% |
How did B7Y perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/06/05 18:22 |
| End of Day Share Price | 2024/04/29 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2023/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Byotrol plc is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Sanders | Arbuthnot Securities Limited |
| David Buxton | Cavendish |
| Andrew Murray Darley | Cavendish |